Incidence of adverse events in patients with metastatic breast cancer during use of standard and on/off capecitabine protocols. Research, Society and Development, [S. l.], v. 11, n. 8, p. e3711830426, 2022. DOI: 10.33448/rsd-v11i8.30426. Disponível em: https://rsdjournal.org/rsd/article/view/30426. Acesso em: 5 dec. 2025.